Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: Central pathology review of the EORTC-26981/NCIC-CE.3 trial
Monika E. Hegi*, Robert Charles Janzer, Wanyu L. Lambiv, Thierry Gorlia, Mathilde C M Kouwenhoven, Christian Hartmann, Andreas Von Deimling, Danielle Martinet, Nathalie Besuchet Schmutz, Annie Claire Diserens, Marie France Hamou, Pierre Bady, Michael Weller, Martin J. Van Den Bent, Warren P. Mason, René Olivier Mirimanoff, Roger Stupp, Karima Mokhtari, Pieter Wesseling
Dive into the research topics of 'Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: Central pathology review of the EORTC-26981/NCIC-CE.3 trial'. Together they form a unique fingerprint.